Beskæftigelsesudvalget 2023-24
BEU Alm.del Bilag 272
Offentligt
2908998_0001.png
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
Contents lists available at
ScienceDirect
International Journal of Hygiene and Environmental Health
journal homepage:
www.elsevier.com/locate/ijheh
The SAM-Krom biomonitoring study shows occupational exposure to
hexavalent chromium and increased genotoxicity in Denmark
Anne Thoustrup Saber
a,*
, Marcus Levin
b
, Pete Kines
a
, Kukka Aimonen
c
, Lucas Givelet
d
,
Christina Andersen
b
, Anja Julie Huusom
e
, Tanja Carøe
f
, Niels Erik Ebbehøj
f
,
Frans Møller Christensen
g
, Zheshun Jiang
h
, Thomas Lundh
h
, Håkan Tinnerberg
i
,
Maria Albin
h,j
, Malin Engfeldt
h,k
, Karin Broberg
a,h
, Julia Catalan
c,l
, Katrin Loeschner
d
,
Karsten Fuglsang
b
, Ulla Vogel
a,d
a
National Research Centre for the Working Environment, 105 Lersø Parkall
´
, DK-2100, Copenhagen
Ø,
Denmark
e
FORCE Technology, 345 Park All
´
, DK-2605, Brøndby, Denmark
e
c
Finnish Institute of Occupational Health, 00250, Helsinki, Finland
d
National Food Institute, Technical University of Denmark, DK-2800, Kgs. Lyngby, Denmark
e
Department of Occupational and Environmental Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
f
Department of Occupational and Social Medicine, Holbæk University Hospital, DK-3400, Holbæk, Denmark
g
COWI A/S, Parallelvej 2, DK-2800, Kgs. Lyngby, Denmark
h
Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
i
Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Sweden
j
Unit of Occupational Medicine, Institute of Environmental Medicine, Karolinska Institutet, Sweden
k
Department of Occupational and Environmental Medicine, Region Skåne, SE-22381, Lund, Sweden
l
Department of Anatomy, Embryology and Genetics, University of Zaragoza, 50013, Zaragoza, Spain
b
A R T I C L E I N F O
Keywords:
Hexavalent chromium
Bath platers
Welding
Biomarkers
Occupational exposure limits
Vocational schools
A B S T R A C T
Background:
Hexavalent chromium (Cr(VI)) is a carcinogen. Exposure to Cr(VI) may occur in different industrial
processes such as chrome plating and stainless steel welding. The aim of this study was to assess occupational
exposure to Cr(VI) in Denmark.
Methods:
This cross-sectional study included 28 workers and 8 apprentices with potential Cr(VI) exposure and 24
within company controls, all recruited from six companies and one vocational school. Use of occupational safety
and health (OSH) risk prevention measures were assessed through triangulation of interviews, a questionnaire
and systematic observations. Inhalable Cr(VI) and Cr-total were assessed by personal air exposure measurements
on Cr(VI) exposed participants and stationary measurements. Cr concentrations were measured in urine and in
red blood cells (RBC) (the latter reflecting Cr(VI)). Genotoxicity was assessed by measurement of micronuclei in
peripheral blood reticulocytes (MNRET).
Results:
At announced visits, a consistent high degree of compliance to OSH risk prevention measures were seen
in ‘chromium bath plating’ for both technical devices (e.g. ventilation, plastic balls, sheet coverings) and in the
use of personal protective equipment (e.g. gloves, respirators), yet a lesser degree of compliance was observed in
‘stainless steel welding’. The geometric mean of the air concentration of Cr(VI) was 0.26
μ
g/m
3
(95% confidence
interval (CI): 0.12–0.57) for the Cr(VI)-exposed workers and 3.69
μ
g/m
3
(95% CI: 1.47–9.25) for the Cr(VI)-
exposed apprentices. Subdivided by company type, the exposure levels were 0.13
μ
g/m
3
(95% CI: 0.04–0.41)
for companies manufacturing and processing metal products, and 0.81
μ
g/m
3
(95% CI: 0.46–1.40) for bath
plating companies. Workers with occupational exposure to Cr(VI) had significantly higher median levels of
urinary Cr (2.42
μ
g/L, 5th-95th percentile 0.28–58.39), Cr in RBC (0.89
μ
g/L, 0.54–4.92) and MNRET (1.59
‰,
0.78–10.92) compared to the within company controls (urinary: 0.40
μ
g/L, 0.16–21.3, RBC: 0.60
μ
g/L,
0.50–0.93,MNRET: 1.06
‰,
0.71–2.06). When sub-dividing by company type, urinary Cr (4.61
μ
g/L, 1.72–69.5),
Cr in RBC (1.33
μ
g/L, 0.95–4.98) and MNRET (1.89
μ
g/L, 0.78–12.92) levels were increased for workers with
potential Cr(VI) exposure in bath-plating companies, and when subdividing by work task, workers engaged in
* Corresponding author.
E-mail address:
[email protected]
(A.T. Saber).
https://doi.org/10.1016/j.ijheh.2024.114444
Received 11 July 2024; Received in revised form 19 August 2024; Accepted 20 August 2024
1438-4639/© 2024 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license
(
http://creativecommons.org/licenses/by/4.0/
).
Please cite this article
as:
Anne Thoustrup
https://doi.org/10.1016/j.ijheh.2024.114444
Saber
et
al.,
International
Journal
of
Hygiene
and
Environmental
Health,
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0002.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
process operation had increased levels of urinary Cr (8.51
μ
g/L, 1.71–69.5), Cr in RBC (1.33
μ
g/L, 0.95–4.98)
and MNRET (1.89
μ
g/L, 0.82–12.92) levels.
Conclusion:
This biomonitoring study shows that bath platers were highly exposed to Cr(VI), as suggested by
relatively high levels of urinary Cr, Cr in RBC and increased levels of micronuclei. The urinary Cr concentrations
were high when compared to the French biological limit value of 2.5
μ
g Cr/L, corresponding to the Danish
occupational exposure limit of 1
μ
g/m
3
. This, in turn, indirectly suggests that additional exposure routes than via
air may contribute to the exposure. For welders, no statistically significant increases compared to within com-
pany controls were observed, however, the observed urinary Cr levels were similar to the levels observed in a
European study (HBM4EU), and were higher than the levels observed for welders in Sweden (SafeChrom). In
spite of a high degree of self-reported and observed compliance to OSH risk prevention measures during
announced visits, the biomarkers of exposure reflecting recent exposure (urinary Cr) or exposure during the last
four months (Cr in RBC) may point to variation in compliance to OSH risk prevention measures in general.
Reduced occupational exposure to Cr(VI) may be achieved by applying the hierarchy of controls in eliminating or
substituting Cr(VI), and the use of more effective technical solutions (e.g. automation).
Abbreviations
BOEL
Biological occupational limit
CI
Confidence interval
Cr
Chromium
Cr(III)
Trivalent chromium
Cr(VI)
Hexavalent chromium
Cr
Tot
Total amount of chromium
DISCO-08 Danish International Standard Classification of
Occupation 2008
EU
The European Union
EPA
Environmental Protection Agency
G-EQUAS German External Quality Assessment Scheme
GM
Geometric mean
GSP
Gesamtstaubprobenahme sampler
HBM4EU The European Human Biomonitoring Initiative
IARC
International Agency for Research on Cancer
ICP-MS Inductively coupled plasma mass spectrometry
LEV
LOD
LOQ
MAG
MIG
MMA
MNRET
NACE
OSH
OEL
P5
P95
PPE
RBC
RBC-Cr
RPE
SOP
TIG
Local exhaustion ventilation
Limit of detection
Limit of quantification
Metal active gas
Metal inert gas
Manual metal arc
Micronuclei in peripheral blood reticulocytes
National version of EU’s nomenclature
Occupational safety and health
Occupational exposure limit
5th percentile
95th percentile
Personal protective equipment
Red blood cells
Chromium concentration in red blood cells
Respiratory protective equipment
Standard operating procedure
Tungsten inert gas
1. Introduction
Hexavalent chromium (Cr(VI)) is a carcinogen (IARC Group 1)
(IARC,
2012).
Exposure to Cr(VI) may occur at different industrial
processes such as chrome plating and stainless steel welding (IARC,
2012).
The main routes of occupational exposure to Cr(VI) are inhala-
tion and dermal contact (IARC,
2012).
In addition, hand to mouth
contact exposure may result in gastrointestinal tract exposure (Beattie
et al., 2017).
In the European Union (EU), occupational exposure to Cr(VI) is
regulated both at the European level and by national occupational
exposure limits (OEL) in some of the member states. The current EU OEL
for Cr(VI) is 10
μ
g/m
3
(IFA,
2024)
which will be further reduced to 5
μ
g/m
3
in 2025 (Santonen
et al., 2022).
Sweden has an OEL of 5
μ
g/m
3
and France, the Netherlands and Denmark have implemented an OEL of
1
μ
g/m
3
(IFA,
2024).
The Danish OEL is expected to be further lowered
to 0.25
μ
g/m
3
in 2025 if deemed technically and economically feasible
(Beskæftigelsesministeriet,
2020).
Chromium (Cr) in the urine is often used as a biomarker of internal
exposure to Cr(VI) (Verdonck
et al., 2021; Viegas et al., 2022).
In
addition to the regulation regarding airborne exposure to Cr(VI), some
European countries have also implemented biological occupational
exposure limits (BOELs) using Cr in urine as a biomarker of Cr(VI).
France and Finland have implemented BOELs of 2.5
μ
g/L and 10
μ
g/L,
corresponding to their OELs of 1 and 5
μ
g/m
3
, respectively (Santonen
et al., 2022).
However, Cr in urine reflects both exposure to Cr(VI) and
trivalent chromium (Cr(III)).
2
The chromium content in the red blood cells (RBC) has been used as a
specific marker for the Cr(VI) exposure because only Cr(VI) and not Cr
(III) can cross the erythrocyte membrane (Devoy
et al., 2016).
The
content of Cr in the erythrocyte reflects the accumulated exposure over
the previous 4 months, corresponding to the lifetime of erythrocytes
(Ndaw
et al., 2022).
Besides internal exposure biomarkers, some early biological effects
can also be assessed from the same human samples, i.e., blood. Flow
cytometric analysis of micronuclei in peripheral blood reticulocytes
(MNRET) is a sensitive high-throughput method for detection of geno-
toxicity in biomonitoring studies (Abramsson-Zetterberg
et al., 2000).
MNRET reflect genotoxicity in bone marrow approximately three days
prior to sample collection. The lifespan of human reticulocytes in blood
circulation is only 1–4 days and micronucleated reticulocytes are effi-
ciently removed by the spleen. Recently, MNRET was successfully used
within the European Human Biomonitoring Initiative (HBM4EU) as a
short-term biomarker of genotoxicity from low Cr(VI) exposure, and
together with other effect biomarkers it contributed to identifying
occupational subgroups that are at increased cancer risk (Tavares
et al.,
2022).
MNRET has also been used for studying the potential genotox-
icity of pesticides (Costa
et al., 2011),
disinfection by-products
(Font-Ribera
et al., 2019),
industrial pollution (Montero-Montoya
et al., 2020),
and polycyclic aromatic hydrocarbons (Andersen
et al.,
2021).
The current SAM-Krom biomonitoring study was initiated in
response to concern in Denmark regarding the risk of occupational
exposure to Cr(VI) in the working environment. The overall purpose of
the project was to assess occupational exposure to Cr(VI) and investigate
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0003.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
whether occupational safety and health (OSH) risk prevention measures
aiming at minimizing workers’ exposure to Cr(VI) were present. The
present paper describes the results of this Danish Cr(VI) study and adds
to a systematic review of biomonitoring data on occupational exposure
to Cr(VI) (Verdonck
et al., 2021),
the recent European HBM4EU Cr(VI)
study (Santonen
et al., 2022)
and the Swedish SafeChrom project (Jiang
et al., 2024).
2. Materials and methods
2.1. Study design and study participants
The study is a cross-sectional study carried out in Denmark. The
study and the questionnaire were designed to be as similar and com-
parable as possible to the two recently published chromium studies: 1)
the HBM4EU study with workers from eight European countries
(Santonen
et al., 2022),
and 2) the SafeChrom study with workers in
Sweden (Jiang
et al., 2024).
The present study contains: 1) Interview
data on company OSH strategy, 2) questionnaire data on self-reported
information from workers and apprentices on work tasks, use of per-
sonal protective equipment (PPE) and life style habits, 3) data from
systematic observations of the use of OSH risk prevention measures, 4)
biomonitoring of biomarkers of exposure and effect in blood and urine,
as well as personal air exposure measurements carried out in five com-
panies and a vocational school, and 5) personal air exposure measure-
ments on workers from one additional workplace and
apprentices/teachers from a vocational school for whom no biological
sampling was performed. The vocational school offers both educations
with and without Cr(VI) exposure. Thus, apprentices with possible Cr
(VI) exposure were recruited for air measurements of Cr(VI) exposure
while apprentices in educations without Cr(VI) exposure were recruited
at a later stage as within company controls.
2.1.1. Recruitment of companies and processes
In the initial stage of the project, a mapping of existing knowledge on
exposure to Cr(VI) in Denmark was performed (Højriis
et al., 2020).
Based on the mapping and a pilot study performing air measurements at
different companies and at different processes, we selected companies
and processes meeting the following criteria: 1. The work entails a risk of
exposure to Cr(VI) and 2. The work task is present at a larger number of
Danish workplaces or exposure occurs repeatedly for the workers
involved. Four work tasks were identified: 1) chromium-containing steel
welding, 2) production of metal-containing products and work with
chromates, 3) thermal spraying, and 4) bath plating (Koponen
et al.,
2021).
Regarding welding type, it was decided to focus on metal active
gas (MAG) welding and
to the extent possible
manual metal arc
(MMA) welding, while omitting tungsten inert gas (TIG) welding, as the
measurements on TIG welding in the pilot study confirmed the
assumption that TIG welding does not entail heavy exposure to Cr(VI)
due to its low mass emission rate and Cr(VI) conversion factor (Fuglsang
et al., 2011; Serageldin and Reeves, 2009).
For the main study, a total number of 29 companies (including four
bath-plating companies and 25 companies with manufacturing/pro-
cessing activities) and one vocational school were contacted by phone.
For the companies that met the inclusion criteria and showed immediate
interest in the study, this was followed up by an e-mail with more details
on the study. Twelve of the 25 manufacturing companies contacted were
omitted, as they were only doing TIG welding in stainless steel. Fifteen of
the remaining, relevant companies (3 bath plating and 12 manufacture/
processing) and the vocational school showed preliminary interest in
taking part in the study. However, due to the COVID 19 pandemic, for
some of the companies there was a delay of 1–2 years from the initial
contact with the companies to the time point when it was possible to
perform the measurements. Meanwhile, the COVID 19 pandemic had
forced some of the companies to change their production or to reduce
their number of workers. Six of the companies (three bath-plating and
3
three manufacture/processing companies) and the vocational school
(MMA welding, black smiths and electricians) agreed to participate in
the study.
2.1.2. Participants recruited for biomonitoring and personal air exposure
assessment
For the biomonitoring part of the study, potentially Cr(VI) exposed
participants were recruited from five companies with potential Cr(VI)
exposure-related activities such as welding or machining in stainless
steel or chromium bath plating. Unexposed participants were recruited
from the same companies among office workers with no activities
related to Cr(VI) exposure (“within company controls”) and from a
vocational school with fields of study not involving activities with Cr(VI)
exposure (“vocational school controls”). An overview of the recruited
exposed and controls stratified by work task on the day the measurement
was performed is presented in
Table 1.
The biomonitoring study was approved by The Scientific Ethics
Committee for the Copenhagen Capital Region (H-20077777). All par-
ticipants were informed orally and received an information folder about
the study before signing a written consent.
2.1.3. Participants only with personal air exposure assessment
In addition to the biomonitoring part of the study, personal air
exposure measurements were performed on the following two groups: 1)
Apprentices from a stainless steel blacksmith training vocational school,
and, 2) Workers from a company with MAG welding activities. The
reasons for only performing personal air exposure assessment and no
collection of biological samples for this group were that: 1) we did not
have an ethical permission for recruiting apprentices for a bio-
monitoring study at the time of these measurements, and 2) the group at
the company consisted almost entirely of non-Danish speaking staff. Our
information material accepted by the ethical committee was in Danish.
2.2. Categorisation of companies and work tasks for exposed workers
The companies were categorized according to the Danish Industrial
Classification (In Danish
“Dansk
Branchekode DB07” (Statistics
Denmark, 2014)
which is a 6-digit classification:
“Dansk
Branchekode
DB07 is the National version of EU’s nomenclature (NACE). The first four
digits refer to NACE rev. 2, while the last two represent the Danish subdivi-
sion”
(Statistics
Denmark, 2014).
The SAM-Krom classification of the
companies was based on the first 3-digits (Supplementary
Table 1).
The job functions for exposed workers were classified according to
Statistics Denmark’s Classification of Occupations (DISCO-08), v1:2010
(Statistics
Denmark, 2010).
DISCO-08 is a 6-digit classification, but we
chose to use only the 3 first digits for our classification (Supplementary
Table 2).
2.3. Interview and questionnaire data
Company leaders with responsibility for OSH were interviewed
regarding company OSH strategy, instruction and training, and pro-
cedures for handling Cr(VI). On the day of the biological sampling, most
participants answered a questionnaire regarding lifestyle habits (e.g.
smoking), work tasks, and use of PPE. Questionnaire items included the
respondents’ use of PPE during various work tasks (chrome [bath]
plating; grinding; processing of surfaces with Cr(VI) content;
manufacturing of metal products containing Cr(VI); office worker visit
to the shop floor) both during the past week and the past three months,
and included fresh air fed respirators (independent), powered air pur-
ifying respirators (without fresh air), reusable (e.g. half and full face
masks) and disposable (single use) respirators, coveralls, gloves and
aprons. For tasks involving welding and hard chromium plating/thermal
spraying, the PPE included welding helmets with or without respirators
as well as fire retardant clothing.
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0004.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
17
11
8
36
6
13
24
Table 1
Categorisation in SAM-Krom of companies/vocational school (n
=
7) and work tasks for individuals (n
=
36, exposed group and n
=
24, control group) for whom biological and/or air sampling were performed.
Total # of individuals
60
A
d
2.4. Systematic safety observations
Systematic observations of exposure control initiatives were regis-
tered in the free app
“Safety
Observer” (nfa.dk/Safetyobserver), where a
tailored list of mandatory chemical exposure control initiatives was
drawn up for visual observation during worksite walk-arounds (Kines
et al., 2010, 2013; Kirkegaard et al., 2018; Nielsen et al., 2015).
The
systematic observations were performed by one member of the research
team at the same time as the initial biomonitoring measurements. The
observation list consisted of Cr(VI) control initiatives in regards to six
topics: 1) order and tidiness (workspaces, disposal areas, access and
escape routes); 2) physical conditions for working with Cr(VI) (safety
signs, labelling, storage, waste); 3) welfare measures (changing, bathing
and dining rooms); 4) first aid (signs and supplies); 5) personal protec-
tive equipment (airway, skin, eyes, ears); 6) technical devices (ventila-
tion, bubble dispensers, mist suppressants, screens and curtains). One
observation marking per object, area (max 50 m
2
), machine, tool, per-
son, etc. was scored as either ‘correct’ or ‘not correct’. Notes and photos
could be added to the observations. Upon completion of the
walk-around in the areas where there were ongoing activities, the app
generated a report and a safety index (%) based on the percent of correct
observations from the total number of observations.
2.5. Personal air sampling and Cr analysis
Measurement of the inhalable fraction of dust was carried out in
accordance with FORCE Technology’s accreditation no. 51 from
DANAK, and following CEN/TS 15230 (CEN,
2005)
and EN 689.
Particles were collected on a PTFE filter (PTFE Membrane Disc Filters
- TF 1000, 1
μ
m, 37 mm) using GSP-3.5 Conical Style Inhalable Dust
Samplers. Collection of inhalable dust was carried out with a sample
flow of 3.5 l/min. Pumps with automatic regulation for constant flow
were used for all measurements, and sample flow was adjusted and
calibrated to 3.50 L/min before each measurement.
The air measurements were carried out at each measurement site
using two identical parallel sampling systems, and the sampling inlets
were both placed in the worker breathing zone outside of any used PPE.
One of the two filters exposed in parallel was analyzed for total chro-
mium (Cr
tot
) and the other for Cr(VI). Blank filters were included for
each measurement site and analyzed together with the samples.
Measurements were carried out during normal work activities. The
collection time varied based on the duration of the relevant work
activities.
Analysis of Cr(VI).
Cr(VI) was extracted with a basic EDTA solution to
avoid reduction of Cr(VI) to Cr(III). Quantification was based on the
addition of the isotope-enriched 50 Cr(VI) using LC-ICP-MS technique.
Extraction and analysis was carried out by Eurofins according to USEPA
SW-846 METHOD 6800 (2007) (U.S,
2007),
and according to Eurofins’
DANAK accreditation no. 168. Eurofins reported the relative expanded
uncertainty of the analysis to be 20%.The LOD was 0.02
μ
g/sample,
which with an airflow of 3.5 L/min and a minimum sampling time of 2 h,
results in a maximum LOD of 0.048
μ
g/m
3
. Thus, the LOD of the air
sampling is well below 0.1
μ
g/m
3
, 10% of the Danish OEL.
Analysis of Cr
Tot
. Extraction and analysis of total chromium followed
ISO15202. Chromium and chromium-containing compounds were
extracted with strong acid and analysis was carried out by Eurofins by
ICP-MS (ISO,
2004).
The LOD was 0.2
μ
g/sample. Eurofins reported the
relative expanded uncertainty of the analysis to be 20%.
The calculation of mean, standard deviation etc. was done by
including all results below the limit of detection (LOD). This was done by
dividing the calculated LOD by 2, and using LOD/2 as the input result in
all calculated statistics.
2.6. Blood and urine sample collection
The biological sampling was performed on the same day as the
4
5
6
13
24
0
0
0
9
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
15
0
Total
11
EB
a
12
9
0
21
Office work/non-metal
work
A
d
0
0
0
0
5
B
c
0
0
0
0
5
E
b
0
0
0
0
0
EB
a
0
0
0
0
0
A
d
1
0
0
1
0
B
c
0
0
0
0
0
E
b
0
0
0
0
0
Others
EB
a
1
0
0
1
0
A
d
5
2
0
7
0
B
c
0
1
0
1
0
Machining
E
b
0
0
0
0
0
EB
a
5
1
0
6
0
A
d
0
9
0
9
0
Process operation
B
c
0
1
0
1
0
E
b
0
0
0
0
0
EB
a
0
8
0
8
0
Work task on sampling day
11
0
8
19
A
d
0
B
c
2
0
0
2
0
11
E
b
3
0
8
0
Welding
EB
a
6
0
0
6
0
0
0
0
0
0
9
0
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
4
6
4
21
Total number of participants
0
0
0
11
E
b
3
0
8
0
0
0
28
B
c
2
2
0
4
5
Controls
Within company controls: Manufacture/processing of metal
products
Within company controls: Bath plating
Within company controls: Vocational school (blacksmiths
welding and electricians)
Exposed
Manufacture/processing of metal products
Bath plating
Vocational school (stainless steel welding)
Categorisation
Total
d
b
a
c
EB: Participants with personal air exposure and biological sampling.
E: Participants only with personal air exposure.
B: Participants only with biological sampling.
A: Participants with any measurement (E or B or (EB).
Companies
n
3
3
1
3
3
1
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0005.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
measurement of inhalable Cr
Tot
and Cr(VI) except for three participants
at one of the bath plating companies, where the air measurements were
performed approximately five months after the biological sampling for
logistical reasons. The blood and spot urine samples were collected on
Wednesdays and Thursdays between 10 a.m. and 2 p.m. (after the
workers had worked for at least 3–5 h). The participants collected a spot
urine sample in an acid-washed cup. Urine samples were transferred to
an acid-washed tube. The urine was kept at 4
C on the sampling day,
and stored at 20
C after transport to NFA. The blood was collected in
two vacutainer tubes: 1) one sodium-heparin for micronuclei, 2) one
sodium-heparin acid-washed tube for analysis of Cr content. The blood
was kept at 4
C on the sampling day. In the afternoon on the sampling
day, after transport to NFA, the erythrocytes were isolated as previously
described (Jiang
et al., 2024).
In brief, the erythrocytes were separated
by centrifugation for 10 min at 1300 g and washed three times with
isotone saline. The washed erythrocytes were kept at 20
C until the
tubes were used for Cr content analysis. On the day after sample
collection, the second sodium-heparin tubes were sent to FIOH for
MNRET analysis.
2.7. Measurement of creatinine and density in urine
Cr content in urine was adjusted for urinary dilution in two different
ways: 1) density of urine, and 2) creatinine. The density of the urine was
measured by weighing. Adjustment of the density was performed ac-
cording to (Jiang
et al., 2024)
using the following formula: C
(densi-
ty-adjusted)
=
C
×
(1-
ρ
mean
)/(1-
ρ
sample density
), where C
=
the determined Cr
concentration in the sample,
ρ
mean
=
the mean of the urinary density of
all participants, and
ρ
sample density
=
the density of the urine sample. The
urine density of three samples was below 1.00 g/mL suggesting that the
urine had been diluted with water. The samples were excluded from the
analysis of density-adjusted Cr content in urine. Creatinine was
measured as previously described (Hansen
et al., 2008).
The molecular
weight of creatinine (113.1 g/mol) was used.
2.8. Measurements of Cr in urine and red blood cells
Tubes and tips were washed with acid (5% HCl and 5% HNO
3
) to
remove metal background contamination. Analysis of Cr content in
urine and blood was performed essentially according to (Jiang
et al.,
2024).
The samples were stored at 4
C prior to the analysis and
thawed at room temperature on the day of analysis. Sample volumes of
250
μ
L (urine) or 100
μ
L (blood) were diluted 20 times in disposable
polypropylene tubes (Sarstedt AG
&
Co. KG, Germany) with an alkaline
solution containing 0.5 g/L EDTA disodium salt dihydrate (Merck,
Darmstadt, Germany), 0.5 g/L Triton X-100 (Sigma-Aldrich, St Louis,
USA) and 5 g/L ammonia (25 %, suprapur, Merck KGaA, Darmstadt,
Germany). The samples were prepared in duplicates (R1 and R2). The
mean values were used in subsequent statistical analyses.
The total mass concentration of Cr in the samples was determined by
inductively coupled plasma-mass spectrometry (ICP-MS) using an iCAP
TQ ICP-MS (Thermo Fisher Scientific, Bremen, Germany) equipped with
an ASX-560 autosampler and a ASXpress PLUS valve equipped with the
1 mL sample loop (Teledyne CETAC Technologies, Omaha, NE, USA).
The analysis was performed in single quadrupole mode with helium as
collision gas in the collision cell (kinetic energy discrimination).
Instrumental configuration and parameters are listed in
Supplementary
Table 3.
For matrix matching of the calibration standards, whole blood
(SERONORM, SERO AS, Billingstad, Norway Whole blood L-1, Lot:
2011920, Cr: 0.61
μ
g/L) and urine (The German External Quality
Assesment Scheme, Erlangen Germay) (G-EQUAS R64/2019 8 A, Cr:
0.25
±
0.09
μ
g/L, were prepared in the same way as the samples and
spiked with Cr concentrations of 0.5, 1, 5 and 10
μ
g/L.
Internal standard correction was performed by spiking 1
μ
g/L
rhodium (Rh) to all samples and calibration standards. Calibration and
5
internal standard were prepared from standard solutions that contained
1000 mg/L of Cr or Rh (PlasmaCAL, SCP Science, Baie D’Urf
´
, QC,
e
Canada).
The analytical accuracy was verified towards certified reference
materials from G-EQUAS and Seronorm. The results (
μ
g/L, mean
±
SD)
obtained for G-EQUAS (Lot. R64/2019 1 A) were for Cr in blood 2.0
±
0.1 vs. range 1.1–2.3 and for Seronorm (Lot, 2011920) in blood 0.70
±
0.12 vs. range 0.48–0.75. For G-EQUAS Cr in urine (Lot. R64/2019 2 A
and 8 A) the results obtained were 3.5
±
0.1 vs. range 2.8–4.0 and 0.22
±
0.02 vs. range 0.16–0.34 respectively. The relative standard deviation
based on triplicate analysis of the certified reference materials was 3 %
for urine and 3.4% for blood (G-EQUAS).
The limit of detection (LOD) and limit of quantification (LOQ),
calculated as 3- and 10-times the standard deviation of the blank sam-
ples, were 0.05 and 0.16
μ
g/L, respectively, for the urine and 0.2 and
0.6
μ
g/L, respectively, for the RBC.
2.9. Analysis of micronuclei frequency
Chromosomal damage was assessed by MNRET as previously
described (Andersen
et al., 2021; Tavares et al., 2022).
Briefly, 2 mL
whole blood samples collected with sodium-heparin were stored at 4
C
and processed within seven days after collection. Immunomagnetic bead
separation was performed according to the instructions of the CELLec-
tion™ Pan Mouse IgG Kit (Invitrogen, Thermo Fisher Scientific, Wal-
tham, MA, USA) to isolate transferrin-positive (+CD71) reticulocytes
using a FITC Mouse Anti-human CD71 antibody (BD Biosciences, San
Jose, CA, USA). Samples were fixed in 2% paraformaldehyde in PBS with
10
μ
g/mL of sodium dodecyl sulfate (SDS; Sigma-Aldrich, Merck KGaA,
Darmstadt, Germany) and stored refrigerated (4
C) until analysis. Prior
to the analysis, each sample was divided into two replicates and DNA
was stained with Hoechst 33 342 (Invitrogen, Thermo Fisher Scientific,
Walthamt, MA, USA). The samples were analyzed with CytoFlex S flow
cytometer (Beckman Coulter, Brea, CA, USA) using blue (488 nm) laser
for the identification of
+CD71
reticulocytes and near UV (375 nm) laser
for the detection of DNA-containing micronuclei. CytExpert software
version 2.3 was used for data acquisition and analysis of 20 000–150 000
+CD71
reticulocytes per replicate sample. The micronuclei frequency
was quantified as per-mille (‰) of micronucleated reticulocytes from all
analyzed
+
CD71 reticulocytes.
2.10. Statistical analysis
Statistical testing was performed using GraphPad Prism 8.0.2. For
continuous variables, statistically significant differences between
exposed and controls were determined using the Kruskal–Wallis test
with Dunn’s post-hoc. Statistically significant differences between
exposed stratified by company and work task and controls were deter-
mined using Kruskal-Wallis test with Dunn’s post-hoc. For categorical
variables, the Chi-square test and Fisher’s exact test were used to
compare differences between exposed and controls. Correlations be-
tween variables were assessed by Spearman’s correlation.
3. Results
3.1. Characteristics of the study population
In total, the study involved 60 individuals including 36 classified as
Cr(VI) exposed and 24 classified as controls. The numbers of participants
with biological sampling and/or personal air exposure assessment across
different company types/vocational schools and work tasks are shown in
Table 1.
The volunteers from the exposed group were recruited from six
companies (three companies performing manufacture/processing of
metal products and three companies performing bath plating) and one
vocational school, where apprentices were taught to perform stainless
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0006.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
steel welding. The exposure measurements and biological sampling
were performed between January 2022 and October 2023.
The volunteers from the control group (n
=
24) were recruited from
the same six companies and the same vocational school as the exposed
group. At the companies, office workers were recruited, and at the
vocational school, apprentices at other educations (electricians, black-
smiths welding) were recruited. Stationary exposure measurements at
relevant locations within the primary working area of the controls were
used as proxies for the personal air exposure for the control group.
The characteristics of the 49 participants (25 exposed and 24 con-
trols) with biological samples are presented in
Table 2.
Both types of controls (within company controls from the six com-
panies and vocational school controls) were regarded as within company
controls, as both are in occupational settings with possible bystander
exposures to Cr(VI). The two types of within company controls differed
from the group of Cr(VI) exposed for some lifestyle characteristics (re-
sults not shown), but much less, when the two types of controls were
merged into one group. For this reason, and to increase the statistical
power, the two types of controls were merged into one within company
control group.
3.2. Interviews, questionnaire and observations regarding OSH risk
prevention
In the interviews with OSH leaders from the six companies (three
bath plating, three manufacture/processing of metal products) and one
vocational school), all were highly aware of the OSH risks of working
with Cr(VI), and had either written or verbal procedures for handling
and working with Cr(VI). Some collaborated with external OSH experts
in carrying out yearly internal OSH meetings, establishing standard
operating procedures (SOPs), carrying out regular air measurements,
etc. Onboarding, instruction and training in Cr(VI) work tasks were most
often done through a learning-by-doing ‘buddy’ system
although most
workers had received some general OSH vocational training. Company
sizes (micro to large) and the degree of systematic OSH work varied
greatly, from a very informal verbal culture, to one company having
attained the ISO4500 international standard for their formal OSH
management system.
In regards to use of PPE and local exhaust ventilation systems,
questionnaire responses were received from 9 of the 11 bath plating
respondents, 12 of the 14 metal manufacturing respondents (welding
and grinding) and 9 of the 13 apprentices serving as within company
controls. For the bath plating workers (in both the previous week and
previous three months) the most often used form of respiratory
Table 2
Characteristics of the study group in Sam-Krom.
Cr(VI) Exposed n
=
25
Age, median (P5, P95)
Female, n (%)
Body Mass Index, median (P5,
P95)
Smoking, n (%)
Never smoker
Previous smoker
Current smoker
Coffee drinking, n (%)
Tea drinking, n (%)
Diet (mix, vegetarian, vegan),
n (%)
Supplement, n (%)
Implant, n (%)
Leisure activity with Cr, n (%)
a
b
c
d
protection were disposable respirators (single use P2/P3 masks), fol-
lowed by powered air purifying respirators (dependent, without fresh
air). Interviews with the OSH leaders and systematic observations of the
work processes revealed that all three bath plating companies used local
exhaust ventilation systems attached to the bath plating equipment, and
also used plastic balls and plastic sheets or cardboard coverings to
reduce aerosol generation for most of the baths. In the three welding and
grinding companies and the vocational school education entailing po-
tential Cr(VI) exposure, they all used local exhaust ventilation with
moveable capture hoods, and the workers/apprentices primarily used
welding helmets without further respiratory protection. However, two
of the workers, who did not fill out the questionnaire, were observed
using air-fed (independent) respirators. Safety observation indexes were
relatively high in both the three bath plating cases (94% average) and
four welding/grinding cases (86% average). The lower indexes in the
welding/grinding cases were partly due to incorrect use of the moveable
capture (ventilation) hoods. Appropriate gloves for the various purposes
(e.g. welding, bath plating) were worn by all workers, and coveralls/
aprons were worn by most workers. The latter were used over a period of
time (shifts) before being washed or replaced.
3.3. Cr(VI) in air
Concentrations of inhalable Cr(VI) measured in the exposed group
and stratified by company and work task are shown in
Table 3
and
Fig. 1.
The geometric mean of the air concentration of Cr (VI) was 0.26
μ
g/m
3
for the workers with potential Cr(VI) exposure and 3.69
μ
g/m
3
for the
apprentices with potential Cr(VI) exposure. When subdividing by com-
pany type, the exposure levels were 0.13
μ
g/m
3
(95% CI: 0.04–0.41) for
companies manufacturing and processing of metal products, 0.81
μ
g/m
3
(95% CI: 0.46–1.40) for bath plating companies and 3.69
μ
g/m
3
(95%
CI: 1.47–9.25) at vocational schools during welding education.
For the workers with potential Cr(VI) exposure, 19 out of 24 (79%)
personal air measurements of inhalable Cr(VI) were below the Danish
OEL of 1
μ
g/m
3
while 10 out of 24 (42%) measurements were below the
expected future Danish OEL of 0.25
μ
g/m
3
(Fig.
2).
When subdividing by company type, two of fifteen air measurements
for companies in manufacturing and processing of metal products
exceeded the Danish OEL of 1
μ
g/m
3
, as did 3/9 measurements for bath
plating companies and 6/8 measurements during welding exercises at
the vocational school. Five of fifteen air measurements for companies in
manufacturing and processing of metal products exceeded the expected
future Danish OEL of 0.25
μ
g/m
3
, as did 9/9 measurements for bath
plating companies and 8/8 measurements during welding exercises at
the vocational school.
3.4. Cr in urine
Controls n
=
24
53 (18.5, 69.8)
4 (16.7)
28.0 (18.6,
58.4)
10 (42)
7 (29)
7 (29)
18 (75)
8 (33)
24/0/0 (100/0/
0)
6 (25)
5 (21)
0 (0)
P
0.69
a
0.03
b
0.80
a
0.50
c
50 (26.3, 66.8)
0 (0)
27.0 (17.5, 46.0)
11 (44)
4 (16)
10 (40)
22 (88)
6 (24)
25/0/0 (100/0/0)
8 (32)
5 (20)
4 (16)
0.24
b
0.47
b
d
0.59
b
>0.99
b
0.04
b
Mann-Whitney test.
Chi-square test.
Fisher’s exact test.
No statistical testing, all participants are on a mixed diet.
6
Urine content of Cr was used as a biomarker of recent exposure to Cr
(VI), while bearing in mind that urinary Cr reflects exposure to Cr(III)
and Cr(VI). Urinary Cr content is presented in three different ways as Cr
content in urine, Cr content normalised to creatinine, and density
adjusted (Table
4).
Urinary Cr was increased in workers with potential
Cr (VI) exposure as compared to controls for all three measures of uri-
nary Cr (Table
4
and
Fig. 3).
Thus, workers with potential occupational
exposure to Cr(VI) had a median Cr of 1.52
μ
g Cr/g crea (5th-95th
percentile 0.25–100) as compared to the controls with a median of 0.31
μ
g Cr/g crea (0.14–4.1). Urinary Cr levels did not differ between within
company controls and vocational school controls (results not shown).
When sub-dividing by company or work tasks, urinary Cr was increased
for workers with potential Cr(VI) exposure at bath-plating companies
(median 3.12
μ
g Cr/g crea (1.72–137.1) compared to controls and when
subdividing by work task, workers engaged in process operation had
significantly increased urinary Cr levels (median Cr level: 3.95
μ
g Cr/g
crea (1.72–137.1)
μ
g Cr/g crea) compared to controls.
The French BOEL of 2.5
μ
g/L Cr was exceeded for 9 out of 11 workers
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0007.png
A.T. Saber et al.
Table 3
Upper panel: concentrations of inhalable total chromium (Cr
Tot
;
μ
g/m
3
) and hexavalent chromium (Cr(VI);
μ
g/m
3
) measured in the exposed group (vocational school apprentices and workers) and within company controls
and stratified by company and work task. Lower panel: stationary measurements of CrTot and Cr(VI) at control locations and locations with potential Cr exposure at the companies.
AIR (PERSONAL)
Cr(VI)
n (n
<
LOD)
m
GM (95% CI)
Median (P5, P95)
Mean (95% CI)
Cr
Tot
n (n
<
LOD)
m
GM (CI)
Median (P5, P95)
Mean (95% CI)
AIR (STATIONARY)
Cr(VI)
n (n
<
LOD)
m
GM (95% CI)
Median (P5, P95)
Mean (95% CI)
Cr
Tot
n (n
<
LOD)
m
GM (CI)
Median (P5, P95)
Mean (95% CI)
a
b
Controls
c
Vocational school Apprentices exposed
d
8 (0)
3.69 (1.47; 9.25)
3.80 (0.80; 20.0)
q
5.98 (0.69; 11.26)
8 (0)
9.99 (5.09; 19.61)
11.85 (2.70; 31.40)
q
12.95 (4.95; 20.95)
Workers exposed
e
24 (5)
0.26 (0.12; 0.57)
0.42 (0.02; 21.74)
q
1.69 ( 0.70; 4.07)
24 (1)
4.49 (2.46; 8.16)
4.03 (0.28; 61.08)
q
10.76 (3.82; 17.69)
Cr companies
j
8 (1)
0.22 (0.05; 0.90)
0.30 (0.011; 1.28)
0.48 (0.09; 0.87)
8 (1)
1.73 (0.61; 4.89)
1.40 (0.25; 14.18)
n
3.39 ( 0.47; 7.26)
COMPANY - TYPE
a
Manufacture/processing
f
15 (5)
0.13 (0.04: 0.41)
0.08 (0.02; 27.96)
n
2.08 ( 1.89; 6.05)
15 (0)
6.86 (3.50; 7.03)
7.47 (1.60; 61.40)
q
14.14 (3.23; 25.05)
Manufacture/processing
k
3 (1)
0.05 (0.00; 4.56)
0.01; 0.36)
0.13 ( 0.35; 0.62)
3 (0)
3.03 (0.11; 83.85)
1.40 (1.40; 14.18)
5.66 ( 12.67; 23.99)
Bath plating
f
9 (0)
0.81 (0.46; 1.40)
0.71 (0.28; 3.10)
p
1.03 (0.36; 1.70)
9 (1)
2.21 (0.69; 7.10)
2.29 (0.25; 19.20)
n
5.11 (0.27; 9.95)
Bath plating
k
5 (0)
0.53 (0.18; 1.54)
0.82 (0.19; 1.28)
o
0.69 (0.11; 1.26)
5 (1)
1.23 (0.28; 5.47)
1.01 (0.25; 5.00)
2.03 ( 0.46; 4.53)
COMPANY - WORK TASK
b
Welding
g
9 (1)
0.24 (0.05; 1.28)
0.22 (0.02; 28.96)
n
3.33 ( 3.77; 10.43)
9 (6)
12.87 (5.74; 28.88)
n
11.20 (3.00; 61.40)
q
21.17 (3.44; 38.89)
Welding
l
Process operation
g
8 (0)
0.86 (0.47; 1.60)
0.79 (0.28; 3.10)
q
1.10 (0.35; 1.86)
8 (1)
1.67 (0.54; 5.31))
1.95 (0.25; 9.10))
3.35 (0.29; 6.41)
Process operation
l
Machining
g
6 (3)
0.09 (0.01; 0.53)
0.06 (0.02; 1.01)
0.27 ( 0.15; 0.69)
6 (0)
3.85 (1.24; 12.01)
n
2.55 (1.60; 19.20)
6.45 ( 1.17; 14.07)
Machining
l
Control location
h
11 (9)
0.017 (0.01; 0.03)
0.011 (0.01; 0.13)
0.03 (0.002; 0.05)
11 (7)
0.35 (0.20; 0.59)
0.39 (0.10; 1.60)
0.46 (0.18; 0.75)
Vocational school
i
7
Endpoints stratified by company type.
Endpoints stratified by company work task. Results from
“Others”
not shown for GDPR reasons (only one participant).
c
No personal air measurements performed among controls.
d
Stars indicates statistically significance following a Mann-Whitney test, stationary control measurements versus vocational school.
e
Stars indicates statistically significance following a Mann-Whitney test, stationary control measurements versus all company exposed.
f
Stars indicate statistically significance by Dunnet’s multiple comparisons test, stationary control measurements versus company types, as a post hoc analysis following a significant Kruskal-Wallis test.
g
Stars indicate statistically significance by Dunnet’s multiple comparisons test, stationary control measurements versus work tasks, as a post hoc analysis following a significant Kruskal-Wallis test.
h
Stationary air measurements performed at control locations (companies and vocational school).
i
No stationary measurements were performed in exposed locations on the vocational school.
j
Stars indicates statistically significance following a Mann-Whitney test, stationary control measurements versus all company exposed.
k
Dunnet’s multiple comparisons test, controls versus work tasks, as a post hoc analysis following a significant Kruskal-Wallis test.
l
No measurements.
m
Number of measurements (number of measurements below LOD.
n
p
<
0.05.
o
p
<
0.01.
p
p
<
0.001.
q
p
<
0.0001.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0008.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
Fig. 1. Inhalable hexavalent chromium (Cr(VI)) in exposed workers across company and work task and in exposed students at a vocational school
A. Inhalable hexavalent chromium (Cr(VI)) in exposed workers across company; B. Inhalable hexavalent chromium (Cr(VI)) in exposed workers across work task; C.
Inhalable hexavalent chromium (Cr(VI)) in exposed apprentices at a vocational school; OEL: Occupatinal exposure limit, Manu./Proces: Manufacture/Processing of
metal products, Process oper.: Process operation; Dunn’s post-hoc test, *P
<
0.05, **P
<
0.01. The data are presented as geometric mean and 95% CI.
3.6. Micronuclei
MNRET was used as a biomarker of recent genotoxic exposure. The
median MNRET frequency was 1.59 (5th-95th percentile: 0.78; 10.92) in
Cr(VI) exposed and 1.06 (0.72; 2.064) in within company controls
(Table
4).
When subdividing by company or work task (Fig.
4),
Cr (VI)-
exposed workers at bath plating companies had increased median levels
of MNRET (1.89 (0.78–12.92)) as compared to controls (1.06
(0.71–2.06) (p
=
0.004), while the level among Cr(VI) exposed workers
at manufacture/processing companies (1.31 (0.79–2.58) was not
increased compared to controls. Similarly, subdividing by work task
revealed that the median level of MNRET for the work task process
operation (1.89 (0.82–12.92)) was significantly increased compared to
controls. The medians for work tasks welding (1.49 (0.79–2.38)) and
machining (0.95 (0.78–6.25)) were not significantly increased
compared to controls.
3.7. Correlation between effect and exposure biomarkers
Correlations between exposure and effect biomarkers are presented
in
Fig. 5
and
Supplementary Fig. 1.
There were strong correlations be-
tween inhalable Cr(VI) and the urinary Cr (unadjusted: Spearman’s rank
correlation coefficients (r
S
)
=
0.75; creatinine adjusted: r
S
=
0.71 and
density adjusted: r
S
=
0.76)). Inhalable Cr(VI) correlated moderately
with the Cr content in RBC (r
S
=
0.52). There were also strong to very
strong correlations between RBC-Cr and all three ways of presenting
urinary Cr (unadjusted: r
S
=
0.77; creatinine adjusted: r
S
=
0.80 and
density adjusted: r
S
=
0.76). The effect biomarker for genotoxicity,
MNRET, correlated moderately to the creatinine adjusted urinary Cr
content (r
S
=
0.40) and moderately and negatively to Cr
Tot
in air (r
S
=
-
0.51).
4. Discussion
This is the first study on Cr(VI) exposure and toxicity in Denmark in
30 years and shows that although the Cr(VI) levels in air have decreased,
particularly bath platers still have an elevated Cr(VI) exposure. Overall,
8
Fig. 2.
Frequency distribution histogram for personal measurements of inhal-
able Cr(VI) at companies.
with potential Cr(VI) exposure at bath plating companies, for 2 out of 14
workers within manufacture and processing and for one out of 24
within-company control. The Finnish BOEL of ca. 10
μ
g/L Cr was
exceeded for 3 out of 11 workers with potential Cr(VI) exposure at bath
plating companies, for none of the workers within manufacture and
processing and for one out of 24 within-company control.
3.5. Cr in red blood cells
Cr in RBC was used as a biomarker of the cumulative exposure to Cr
(VI) the last 4 months (Table
4).
Cr(VI) content in RBC was increased in
workers with potential Cr(VI) exposure (median level: 0.89
μ
g/L (95%
CI: 0.54–4.9) as compared to controls (median: 0.60 (0.50–0.93) (P
<
0.0001). Levels of Cr(VI) in red blood cells did not differ between within
company controls and vocational school controls (results not shown).
When subdivided by company type and work task, workers with po-
tential Cr(VI) exposure at bath plating companies had significantly
increased blood levels of Cr(VI) (P
<
0.0001), as had process operators
(P
<
0.0001) when subdivided by work task (Fig.
4
and
Table 4).
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0009.png
A.T. Saber et al.
Table 4
Chromium (Cr) concentration in urine and red blood cells (RBC) and micronucleus assay in reticulocytes (MNRET).
URINE
Cr
Unadjusted
Median (P5, P95)
Mean (95% CI)
Creatinine adjusted
Median (P5, P95)
Mean (95% CI)
Density adjusted
i
Median (P5, P95)
Mean (95% CI)
BLOOD
RBC-Cr
Median (P5, P95)
Mean (95% CI)
MNRET
j
Median (P5, P95)
Mean (95% CI)
Unit
Unit
Controls
c
n¼24
0.40 (0.05; 6.44)
0.78 (0.10; 1.46)
Workers exposed
d,e
n¼25
1.47 (0.2; 50.7)
m
5.66 (0.29; 11.0)
n¼25
1.52 (0.25; 100)
m
7.74 ( 3.46; 18.93)
n¼24
2.42 (0.28; 58.39)
m
6.98 (0.85; 13.10)
Workers exposed
d,e
n¼25
0.89 (0.54; 4.92)
m
1.41 (0.86; 1.96)
n¼25
1.59 (0.78; 10.92)
k
2.27 (1.22; 3.32)
COMPANY
a
Manufacture/processing
f
Bath plating
g
n¼11
4.68 (1.47; 64.6)
n
11.69 ( 059; 23.96)
n¼11
3.12 (1.72; 137.1)
n
16.6 ( 10.37; 43.56)
n¼11
4.61 (1.72; 69.5)
l
13.55 (0.23; 26.87)
Bath plating
g
n¼11
1.33 (0.95; 4.98)
n
2.28 (1.16; 3.41)
n¼11
1.89 (0.78; 12.92)
l
3.35 (0.96; 5.74)
n¼14
0.56 (0.14; 3.91)
0.94 (0.36; 1.52)
n¼14
0.50 (0.20; 2.0)
0.78 (0.48; 1.07)
n¼13
0.69 (0.28; 5.89)
1.41 (0.41; 2.42)
Manufacture/processing
f
n¼14
0.71 (0.52; 1.00)
0.72 (0.65; 0.80)
n¼14
1.31 (0.79; 2.58)
1.42 (1.07; 1.76)
WORK TASK
b
Welding
n¼8
0.55 (0.10; 2.30)
0.80 (0.22; 1.38)
n¼8
0.65 (0.44; 2.0)
0.87 (0.42; 1.32)
n¼7
1.15 (0.35; 5.89)
1.79 (0.03; 3.56)
Welding
n¼8
0.74 (0.52; 1.00)
0.74 (0.63; 0.85)
n¼8
1.49 (0.79; 2.38)
1.41 (0.98; 1.84)
Process operation
h
n¼9
4.70 (1.50; 64.6)
n
13.51 ( 1.78; 28.8)
n¼9
3.95 (1.72; 137.1)
n
19.7 ( 14.3; 53.7)
n¼9
8.51 (1.71; 69.5)
l
15.80 ( 0.69; 32.32)
Process operation
h
n¼9
1.33 (0.95; 4.98)
n
2.49 (1.11; 3.88)
n¼9
1.89 (0.82; 12.92)
l
3.32 (0.45; 6.18)
Machining
n¼7
0.90 (0.40; 5.0)
1.89 (0.19; 3.59)
n¼7
0.95 (0.38; 3.1)
1.3 (0.32; 2.23)
n¼7
0.69 (0.30; 4.21)
1.77 (0.20; 3.34)
Machining
n¼7
0.84 (0.59; 1.43)
0.89 (0.57; 1.20)
n¼7
0.95 (0.78; 6.25)
2.06 (0.22; 3.90)
μ
g Cr/L
μ
g Cr/g crea
n¼24
0.31 (0.14; 4.1)
0.62 (0.19; 1.04)
μ
g Cr/L
n
¼22
0.40 (0.16; 21.3)
1.72 ( 0.57; 4.00)
Controls
c
n¼24
0.60 (0.50; 0.93)
0.63 (0.58; 0.68)
μ
g Cr/L
n¼24
1.06 (0.71; 2.06)
1.14 (0.99; 1.30)
9
P5: 5th percentile; P95: 95th percentile; 95% CI: 95% confidence interval.
a
Endpoints stratified by company type.
b
Endpoints stratified by company work task. Results from
“Others”
not shown for GDPR reasons (only one participant).
c
All controls (within company controls
+
vocational school controls).
d
All company exposed.
e
Stars indicates statistically significance following a Mann-Whitney test, controls versus all company exposed.
f
Manufacture/procession used as abbreviation of Manufacture/procession of metal products.
g
Stars indicate statistically significance by Dunnet’s multiple comparisons test, controls versus company types, as a post hoc analysis following a significant Kruskal-Wallis test.
h
Stars indicate statistically significance by Dunnet’s multiple comparisons test, controls verus work tasks, as a post hoc analysis following a significant Kruskal-Wallis test.
i
Three samples were taken out due to a negative density (2 from the control group and 1 from the exposed group).
j
Chromosomal damage assessed by the micronucleus assay in reticulocytes (MNRET).
k
p
<
0.05.
l
p
<
0.01.
m
p
<
0.001.
n
p
<
0.0001.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0010.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
Fig. 4. Red blood cell Cr (RBC-Cr) and micronuclei in peripheral blood
reticulocytes (MNRET) in controls and exposed workers across company
and work task
A. RBC; B. MNRET; Manu./Proces: Manufacture/Processing of metal products,
Process oper.: Process operation; Dunn’s post-hoc test, ****P
<
0.0001. The
data are presented as median and interquartile range.
Fig. 3. Urinary Cr in controls and exposed workers across company and
work task
A. Urinary Cr (unadjusted); B. Urinary Cr (density adjusted); C. Urinary Cr
(creatinine adjusted); Manu./Proces: Manufacture/Processing of metal prod-
ucts, Process oper.: Process operation; Dunn’s post-hoc test, **P
<
0.01, ****P
<
0.0001. The data are presented as median and interquartile range.
10
the SAM-Krom biomonitoring study recruited 60 subjects including 36
with possible occupational exposure to Cr(VI) and 24 without occupa-
tional exposure to Cr(VI). The company types included were selected
based on a report reviewing the current knowledge on occupational
exposure to Cr(VI) in Denmark (Højriis
et al., 2020).
The report
concluded that manufacturing and processing was the company cate-
gory with the highest number of workers with possible Cr(VI) exposure,
while bath plating represented companies with possible high occupa-
tional exposure to Cr(VI) (Højriis
et al., 2020).
The report estimated that
there are 5–7 Danish bath plating companies with 10–49 workers with
possible occupational exposure to Cr(VI) and ca. 5.000–20.000 workers
in welding, thermal cutting and sanding in stainless steel who are
potentially occupationally exposed to Cr(VI) (Højriis
et al., 2020).
For
welding, we recruited companies doing MAG and MMA welding in
stainless steel as these are the primary types of welding entailing Cr(VI)
exposure (Højriis
et al., 2020).
We included three bath-plating com-
panies encompassing 11 participants with possible occupational expo-
sure to Cr(VI) and 6 within company controls. Thus, the SAM-Krom
study included a substantial fraction of the bath-plating companies and
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0011.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
Fig. 5. Scatter plot and Spearman correlation analysis between inhalable Cr(VI), red blood cells Cr (RBC-Cr), urine Cr/density, urine Cr/Crea and
micronuclei in peripheral blood reticulocytes (MNRET) in the exposed group.
A. Urine Cr/density versus inhalable Cr(VI); B. RBC-Cr versus inhalable Cr(VI); C. RBC-Cr versus urine Cr/density; D. MNRET versus Urine Cr/Creatinine.
bath platers in Denmark. In
Supplementary Table 4,
results from
SAM-Krom are compared to the Swedish SafeCrom and the European
HBM4EU results.
4.1. Cr(VI) in air
Air concentrations of Cr(VI) were measured for 3.0 h on average,
thus reflecting 37.5% of an 8-h work day. Assuming that the air mea-
surements are representative for an 8-h working day, the air concen-
tration of Cr(VI) in the working areas of the within company controls
was low (0.017
μ
g/m
3
, (95% CI: 0.01; 0.03) and most of the measure-
ments were below the limit of detection. For workers with possible
occupational exposure to Cr(VI), the geometric mean for Cr(VI) expo-
sure was significantly increased and more than 10 times higher; 0.26
μ
g/
m
3
, (95% CI:0.12; 0.57), while still below the Danish OEL. When sub-
diving by company type, bath plating companies had significantly
higher Cr(VI) concentrations in the air (geometric mean (GM): 0.81
μ
g/
m
3
(95% CI: 0.46; 1.40) as compared with within company offices and as
compared to air levels within manufacturing (GM: 0.13
μ
g/m
3
(95% CI:
0.04: 0.41). We measured rather high Cr(VI) exposure levels (GM: 3.69
μ
g/m
3
, (95% CI: 1.47; 9.25) for trainees performing MMA welding at a
vocational school, highlighting the need to increase the focus on OSH
risk preventive measures and training in using the preventive measures
11
in the education and training processes.
Knudsen et al. (1992)
performed a biomonitoring study of occupa-
tional exposure to Cr(VI) among 127 welders and 80 reference persons
in Denmark in 1987 (Knudsen
et al., 1992).
Knudsen et al. reported air
exposure levels to chromates as geometrical means of 0.9
μ
g/m
3
(0.4
μ
g
Cr(VI)/m
3
), 1.4
μ
g/m
3
(0.6
μ
g Cr(VI)/m
3
) and 1.5
μ
g/m
3
(0.7
μ
g Cr
(VI)/m
3
) for TIG, MMA
+
TIG, and metal inert gas (MIG) welders,
respectively, thus reporting 2–3 times higher Cr(VI) air concentrations
than in the current study (GM for welding: 0.24
μ
g/m
3
(95% CI: 0.05;
1.28).
Bonde and Christensen (1991)
assessed Cr exposure in 60 welders
and 45 reference persons at Danish workplaces and reported median
values of time-weighted average exposure to Cr(VI) in air (Bonde
and
Christensen, 1991).
For TIG welders in stainless steel, Cr(VI) was 3
μ
g/m
3
and for mild steel welding, 1
μ
g/m
3
was reported. The corre-
sponding median Cr(VI) air concentration for welders in the current
study was 0.2
μ
g/m
3
, (95% CI: 0.02; 28.96). Thus, the occupational
exposure levels to Cr(VI) for welders seem to be lower as compared with
the two more than 30-year-old Danish studies on welders. When
comparing to contemporary studies, the Swedish SafeChrom study, re-
ported similar levels as in the present study: GM for welders as 0.17
μ
g/m
3
, (95% CI: 0.08–0.37) and the median 0.1
μ
g/m
3
, (P5-95:
0.02–14.73) (Jiang
et al., 2024).
In the large HBM4EU study, GM for Cr
(VI) measured outside any respiratory protective equipment (RPE) was
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0012.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
0.5
μ
g/m
3
and median air concentration was also 0.5
μ
g/m
3
.
In the current study, Cr(VI) exposure levels for the work task process
operation, representing bath plating was GM: 0.86
μ
g/m
3
, (95% CI:
0.47; 1.60). In SafeChrom, process operation (representing bath plating)
had GM of 0.19
μ
g/m
3
Cr(VI) (95% CI: 0.12–0.31), while HBM4EU re-
ported a GM of 0.3
μ
g Cr(VI)/m
3
outside RPE. Thus, in comparison with
the Swedish and the pan-European study, the Danish Cr(VI) levels for
bath plating were relatively high, being 3–5 fold higher as compared to
the other contemporary European studies.
4.2. Exposure biomarkers
For all biomarkers of Cr(VI) exposure, bath platers had highly
increased levels compared to controls, whereas welders represented in
the category manufacturing and processing of metal products did not
differ from the controls for any of the biomarkers of exposure.
4.2.1. Urinary Cr
Kristiansen et al. (1997)
reported a reference interval for urinary Cr
in the general population in Denmark to be a mean
±
standard deviation
of 5.2 nmol/L
±
4.1 nmol/L corresponding to 0.27
μ
g/L
±
0.21
μ
g/L
(Kristiansen
et al., 1997).
Median values were 4.2 nmol/L corresponding
to 0.22
μ
g/L with a 95% CI of 0.20–1.35
μ
g/L. In the present study, the
within company controls had a mean urinary Cr of 0.78
μ
g/L and a
median of 0.4
μ
g/L Cr. These values are higher than the reference values
and higher than the outwith company controls in the Swedish Safe-
Chrom study, where median post-shift urinary Cr values of 0.11
μ
g/L
were reported (Jiang
et al., 2024).
This probably reflects that the within
company controls in the current study were exposed to Cr to some
extent. This is in agreement with the findings from the large European
HBM4EU study (Santonen
et al., 2022; Viegas et al., 2022),
who re-
ported higher urinary Cr for within company controls than for outwith
company controls. HBM4EU reported urinary Cr for within company
controls with median value of 0.3
μ
g Cr/g Crea, which is similar to the
median urinary Cr for within company controls in the present study of
0.31
μ
g Cr/g Crea. In comparison, the HBM4EU outwith company
controls had median urinary Cr of 0.1
μ
g Cr/g Crea, which is in line with
the SafeChrom study outwith controls (median urinary Cr: 0.10
μ
g Cr/g
Crea). Taken together, this suggests that the within company controls in
the present study have increased urinary Cr as compared to Danish
reference values and as compared to outwith company controls from
other studies.
Occupational exposure to Cr(VI) via Cr in urine has been assessed in
the two previously mentioned Danish studies of welders. The reference
persons were metalworkers and electricians. In
Bonde and Christensen
(1991),
MMA/stainless steel welders had median urinary Cr of 0.635
μ
g
Cr/g Crea, TIG/stainless steel welders a median urinary Cr of 0.95
μ
g
Cr/g Crea and mild-steel welders a urinary Cr of 0.60
μ
g Cr/g Crea
(Bonde
and Christensen, 1991).
Metalworkers and electricians had
median urinary Cr levels of 0.34 and 0.32
μ
g Cr/g Crea, respectively
(Bonde
and Christensen, 1991).
In the study by
Knudsen et al. (1992),
the average post-shift mean Cr concentrations in urine from exposed
stainless steel welders varied from 2.38 to 7.85
μ
mol/mol creatinine or
0.78–2.16
μ
g Cr/g Crea. The reference group had a mean urinary Cr of
0.37
±
0.37
μ
g Cr/g Crea. In comparison, within company controls in
the present study have very similar median urinary Cr (0.31
μ
g Cr/g
Crea) as the reference persons in the 30-year-old studies by Bonde
(Bonde
and Christensen, 1991).
The mean urinary Cr for within com-
pany controls in the present (0.62
μ
g Cr/g Crea) is higher than the mean
urinary Cr of 0.37
μ
g Cr/g Crea in
Knudsen et al. (1992).
The welders in
the current study had a median urinary Cr level of 0.65
μ
g Cr/g Crea,
which is similar to the urinary Cr levels reported by
Bonde (1991)
for
MMA and mild steel welders. The welders in the current study had a
mean urinary Cr level of 0.87
μ
g Cr/g Crea, which is similar to the
urinary mean Cr for MIG welders but lower than the urinary mean Cr
values for MMA
+
TIG and TIG welders in Knudsen et al. The urinary Cr
12
levels in welders in the current study was similar to the levels reported
by HBM4EU (post-shift urinary Cr: median value 0.7
μ
g Cr/g Crea and
mean value: 1.1
μ
g Cr/g Crea). Conversely, urinary Cr for welders was
lower in the Swedish SafeChrom study (median urinary Cr: 0.41
μ
g Cr/g
Crea). However, the type of welders in the present study and the
Swedish study differed as the Swedish study included TIG welding and
the values may therefore not be directly comparable. In the bath plating
companies, Cr(VI) exposed workers had median urinary Cr value (4.68
μ
g/L) that exceeds the French BOELs of 2.5
μ
g/L. Similarly, workers
with the work task ‘process operation’ (i.e. performing bath plating) had
a median urinary Cr value of 4.70
μ
g/g Crea. In comparison, bath platers
in HBM4EU had median urinary Cr levels of 1.1
μ
g Cr/g Crea (Viegas
et al., 2022),
and in SafeChrom, workers at bath plating companies had
urinary Cr levels of 0.56
μ
g Cr/g Crea (Jiang
et al., 2024).
Thus, the
Danish bath plates have much higher urinary Cr levels as compared to
the Swedish and the European studies.
4.2.2. Cr in RBC
In the current study, workers with occupational exposure to Cr(VI)
had significantly higher Cr levels in RBCs as compared to within com-
pany controls. When subdividing by company type, only workers within
bath plating had significantly increased RBC levels of Cr (VI).
In the Swedish SafeChrom study, workers at bath-plating companies
had median RBC levels of Cr of 0.83
μ
g/L. Bath platers in HBM4EU
(Ndaw
et al., 2022)
had higher RBC levels of Cr (median value 4.34
μ
g/L) as compared to 1.33
μ
g/L in the current study for both Cr(VI)
exposed workers at bath plating companies and workers with the work
task ‘process operation’.
4.3. Interviews, questionnaire and observations of OSH risk prevention
Triangulation regarding OSH risk prevention through the use of in-
terviews, a questionnaire and systematic safety observations revealed
consistent results in terms of use of PPE and technical assistive devices
such as local exhaust ventilation systems, and the use of plastic balls and
sheet or cardboard coverings to reduce aerosol formation in bath
plating. The relatively high OSH compliance rate reflected by the sys-
tematic safety observation safety indexes may be due to heightened
attention given to the various data collectors by the companies on the
day of data collection, as data were mainly collected on announced visits
by the research team on the same day for both biomonitoring, air
sampling, interviews, questionnaires and safety observations.
A recent systematic review on occupational exposure to Cr(VI) pro-
vides evidence of the use of OSH risk prevention measures such as
technical solutions, PPE, job-rotation and limiting lengths of shift-work
(Verdonck
et al., 2021).
A study in nine European countries (HBM4EU
project) concluded that use of PPE in bath plating and welding showed
lower urinary Cr (Viegas
et al., 2022).
In addition, results from the
recent SafeChrom study in Sweden with visual observations in 113 Cr
(VI) exposed workers showed lower levels of both compliance to use of
local exhaustion ventilation and proper use of respiratory protective
equipment (Jiang
et al., 2024).
The authors of the study from Sweden
concluded that local exhaustion ventilation had a greater preventive
effect than respiratory protective equipment, and that the results suggest
that the use of respiratory protective equipment is inadequate due to
factors such as other exposure routes, irregular use or premature
removal of respiratory protective equipment during exposure, as well as
lack of fit test presumably leading to leaking from the mask when worn
(Jiang
et al., 2024).
Qualitative and quantitative fit testing can
contribute to more effective use of respiratory protective equipment
(HSE,
2019),
however results of the current study reinforce the need to
focus on applying the upper levels of the hierarchy of controls with
eliminating or substituting Cr, and through the use of more effective
technical solutions (e.g. automation) in reducing occupational exposure
to Cr(VI), as supplements to the use of organizational measures (e.g. job
rotation), and worker related measures (e.g. instruction, training and
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0013.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
use of personal protective equipment).
4.4. Cr(VI) exposure in welders
In the current study, welders were statistically significantly exposed
to Cr(VI) when assessed by air measurement but not by measurement of
the actual exposure in blood or urine. However, the reason for this may
primarily be the modest statistical power caused by the limited number
of welders (n
=
7–9) and the use of within company controls who have
low Cr(VI) exposure. Comparing our findings to the data from the 30-
year-old Danish studies of welders, may suggest that the Cr(VI) expo-
sure of welders may have decreased over time as Cr(VI) in air was lower
in the current study as compared to (Bonde
and Christensen, 1991;
Knudsen et al., 1992).
However, the urinary Cr levels for welders in the
current study were not substantially different from the reported levels in
older Danish studies, and quite similar to the levels reported in the
HBM4EU study. Notably, lower urinary Cr level were reported in the
Swedish SafeChrom study. Despite the lower urinary Cr levels, urinary
Cr was correlated positively with welding in linear regression analyses
in the SafeChrom study (Jiang
et al., 2024).
This, in turn, suggests that
for the Swedish welders, the increased urinary Cr levels were likely
caused by occupational exposure.
4.5. Cr(VI) exposure in bath platers
We consistently found indications that workers with possible Cr(VI)
exposure in path plating companies and workers with the work task
‘process operation’ (i.e. bath plating) had increased Cr(VI) exposure in
terms of Cr(VI) in air, urinary Cr and Cr levels in red blood cells. Urinary
Cr exceeded the French BOELs of 2.5
μ
g/L, which corresponds to an OEL
of 1
μ
g/m
3
for bath plating, even though only a few air measurements
exceeded the Danish OEL assuming that the air measurement are
representative for an 8-h working day. This may indirectly suggest that
other routes of exposure may contribute to Cr(VI) exposure in addition
to inhalation. Both the interviews, questionnaires and systematic safety
observations suggested high OSH compliance - at least on the day of
observation. However, the biomarkers of exposure reflecting recent
exposure (urinary Cr) or exposure during the last 4 months (Cr in RBC)
may point to variation in OSH compliance in general. Similar high Cr
exposure of bath platers was found in HBM4EU (Viegas
et al., 2022),
who suggested that oral exposure by hand to mouth contact may
contribute to Cr(VI) exposure. In addition, in the HBM4EU study, it was
shown that automated bath plating significantly reduced urinary Cr
(Viegas
et al., 2022).
4.6. Micronuclei
Genotoxicity was assessed in terms of MNRET in the current study.
We found that Cr(VI) exposed workers had increased levels of MNRET as
compared to within company controls. Specifically, workers in bath
plating companies and workers with the work task ‘process operation’
had increased levels of MNRET as compared to within company controls
(median micronuclei frequencies 1.89, 1.89 and 1.06, respectively.).
Taken together with the increased levels of biomarkers of Cr(VI) expo-
sure, this suggests that the increased MNRET levels may be attributed to
occupational exposure.
In the HBM4EU chromate study, several biomarkers of genotoxicity
were studied including MNRET. In general, levels of biomarkers of
genotoxicity were increased in Cr(VI) exposed workers as compared to
outwith company controls but not as compared to within company
controls (Tavares
et al., 2022).
Specifically, MNRET levels were
increased for all Cr(VI) exposed as compared to outwith company con-
trols, and MNRET for welders was increased as compared to both out-
with and within company controls. Of note, MNRET was assessed for
four countries (Belgium, Finland, Poland and Portugal) and outwith
company controls were only available for Portugal and Finland.
13
Knudsen et al. (1992)
also assessed biomarkers of genotoxicity and
reported increased levels of chromosomal aberrations in stainless steel
welders as compared to within company controls (Knudsen
et al., 1992).
Our results agree with those previous studies reporting chromosome
damage. A major genotoxic effect of Cr(VI) that contributes to carci-
nogenesis is the formation of DNA adducts, which can lead to DNA
damage (Alur
et al., 2024).
Intracellular reduction of Cr(VI) results in
the generation of Cr(III), which forms several types of Cr-DNA adducts.
If not properly repaired, Cr-DNA adducts may generate mutations and
DNA double-stranded breaks (Krawic
and Zhitkovich, 2023),
which can
give rise to micronuclei and chromosome aberrations.
Whereas increased levels of micronuclei in peripheral blood lym-
phocytes have shown to be predictive of cancer risk in prospective
studies (Bolognesi
et al., 2021; Bonassi et al., 2007; Dhillon et al., 2021),
analysis of MNRET is a recent tool in human biomonitoring studies
(Costa
et al., 2011)
and has not yet been assessed for predictivity of
cancer risk. Nevertheless, MNRET is a promising mutagenicity
biomarker, especially as indicator of potential leukemogenic agents
(Albertini
and Kaden, 2020).
4.7. Study strengths and limitations
This study on occupational exposure to Cr(VI) is to our knowledge
the first in Denmark in 30 years. We used the same study protocol and
questionnaires as the Swedish SafeChrom study and the large HBM4EU
study with some modifications. Cr exposure in air was quantified using
accredited methods that were aligned with the Swedish SafeChrom
study. Thus, air measurements were performed according to the US EPA
and Cr(VI) content in inhalable dust was quantified by LC-ICP-MS
technique according to US EPA. For Cr in urine and blood, the work
was based on the analysis protocol from
Jiang et al., 2024)
with an
adapted volume of urine sampled (250
μ
L), a similar dilution factor and
the same alkaline solution for the dilution (Jiang
et al., 2024).
For ma-
trix matching of the calibration standards, SERNORM Whole blood L-1,
Lot: 2011920 and urine GEQUAS 64/2019 8 A were prepared in the
same way as the samples and spiked with Cr. Inductively coupled plasma
mass spectrometry (ICP-MS), as applied in this study, was one of the two
methods that was evaluated as appropriate for the determination of
chromium in urine and whole blood regarding occupational exposure
levels by the HBM4EU quality assurance program (Nübler
et al., 2022).
The LOQs in this study (0.16
μ
g/L for urine and 0.60
μ
g/L for blood)
were below or similar to the mean LOQs reported in the HBM4EU
inter-laboratory comparison (0.27–0.42
μ
g/L for urine and 0.42–0.95
μ
g/L for whole blood, depending on test round). The selected reference
materials in this study had concentrations close to the low-level control
materials used in the inter-laboratory comparison and satisfying preci-
sion and trueness were obtained. Thus, the current study should be
comparable to the SafeChrom and HBM4EU studies (Jiang
et al., 2024;
Santonen et al., 2022).
Furthermore, the present study describes NACE
and ISCO-codes for the study population, which adds to transparency,
and facilitates replication and pooling of the data.
The current study has a number of limitations. The most important
limitation is the limited number of participants mainly caused by Covid-
19 lock-downs. Challenges in the recruiting of companies and employees
were also highlighted by the HBM4EU study (Galea
et al., 2021).
Furthermore, we note that the companies who agreed to participate
likely represent companies who have special interest in occupational
health and safety, and thus, may not be representative for the entire
field, potentially leading to underestimation of the true exposure and
accompanying risks. In addition, we only included employees who were
able to read and write in Danish, again potentially introducing bias in
the representativeness of the study participants. Another limitation is
that Cr(VI) was only measured once for each study participant. We only
collected one urine sample per day instead of morning and end-of-shift
samples for logistic reasons. Both the HBM4EU study and SafeChrom
convincingly showed increased urinary Cr levels in Cr(VI)-exposed
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0014.png
A.T. Saber et al.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
workers could be attributed to occupational exposure (Jiang
et al., 2024;
Santonen et al., 2022).
The Cr(VI)-exposed group were all male, whereas
there were 4 women among the controls. The study group also included
present smokers, even though smoking is suggested to contribute to Cr in
blood and urine as well as MNRET (Offer
et al., 2005).
Of note, smoking
status did not influence urinary Cr in a study of reference levels in Danes
(Kristiansen
et al., 1997).
Due to the limited statistical power, we did not
adjust the analyses for age, sex and smoking status. Of note, these ad-
justments did not influence the results in the SafeChrom study (Jiang
et al., 2024).
As the air measurements for most of the participants were
done on the same day as the biological sample collection they may differ
from the exposure levels present 3 days prior to day of measurement,
which is the time when the RETMN were formed. Furthermore, three of
the air measurements at one of the bath plating companies were per-
formed five months after the biological sampling. However, the
day-to-day variation in the exposure from the baths is assumed to be
small, as the main source of Cr(VI) exposure is the baths. Another lim-
itation is that the Cr(VI) air exposure levels were only measured for 3 h
thus not reflecting an 8 h working day. If the worker change work task
during the day this may influence the average daily exposure level.
5. Conclusion
The SAM-Krom study shows that bath platers are highly exposed to
Cr(VI) as suggested by relatively high urinary Cr levels, Cr levels in RBC
and increased levels of micronuclei. The urinary Cr levels were high as
compared to the BOEL corresponding to 1
μ
g/m
3
, thus indirectly sug-
gesting that additional exposure routes contribute to the exposure. For
welders, no statistically significant increases as compared to within
company controls were observed, however, the observed urinary Cr
levels were similar to the levels observed in HBM4EU and higher than
the levels observed for welders in SafeChrom. On the announced visits, a
consistent high degree of compliance to OSH risk prevention measures
was seen in bath plating for both technical devices (ventilation, plastic
balls, coverings) and use of personal protective equipment, and to a
lesser degree of compliance to OSH risk prevention measures in welding
with stainless steel. However, the biomarkers of exposure reflecting
recent exposure (urinary Cr) or exposure during the last 4 months (Cr in
RBC) may point to variation in OSH compliance in general. This, in turn,
may imply that a more consistent focus on OSH risk prevention mea-
sures, according to the upper levels of the hierarchy of controls (e.g.
substituting Cr, automation), would reduce occupational exposure to Cr
(VI).
CRediT authorship contribution statement
Anne Thoustrup Saber:
Writing
review
&
editing, Writing
original draft, Project administration, Methodology, Investigation,
Funding acquisition, Formal analysis, Data curation, Conceptualization.
Marcus Levin:
Writing
review
&
editing, Investigation, Formal anal-
ysis, Data curation.
Pete Kines:
Writing
review
&
editing, Methodol-
ogy, Investigation, Funding acquisition, Formal analysis, Data curation,
Conceptualization.
Kukka Aimonen:
Writing
review
&
editing, Re-
sources, Investigation.
Lucas Givelet:
Writing
review
&
editing,
Investigation, Formal analysis, Data curation.
Christina Andersen:
Writing
review
&
editing, Investigation, Formal analysis, Data cura-
tion.
Anja Julie Huusom:
Writing
review
&
editing, Investigation.
Tanja Carøe:
Writing
review
&
editing, Investigation.
Niels Erik
Ebbehøj:
Writing
review
&
editing, Methodology, Conceptualization.
Frans Møller Christensen:
Writing
review
&
editing, Project admin-
istration, Methodology, Investigation, Funding acquisition, Conceptu-
alization.
Zheshun Jiang:
Writing
review
&
editing.
Thomas Lundh:
Writing
review
&
editing.
Håkan Tinnerberg:
Writing
review
&
editing.
Maria Albin:
Writing
review
&
editing.
Malin Engfeldt:
Writing
review
&
editing.
Karin Broberg:
Writing
review
&
editing,
Funding acquisition.
Julia Catalan:
Writing
review
&
editing,
14
Methodology, Funding acquisition.
Katrin Loeschner:
Writing
review
&
editing, Methodology, Investigation, Formal analysis, Data curation.
Karsten Fuglsang:
Writing
review
&
editing, Methodology, Investi-
gation, Funding acquisition, Conceptualization.
Ulla Vogel:
Writing
review
&
editing, Writing
original draft, Validation, Supervision, Re-
sources, Methodology, Funding acquisition, Conceptualization.
Acknowledgements
The technical assistance from Ismo Koponen, Anne Abildtrup, Noor
Irman and Ulla Tegner is gratefully acknowledged. A special thanks goes
to the participating companies and vocational school. We are also
grateful to the study participants for their time and willingness put into
this study. We established a reference group which includes stake-
holders from e.g. the social partners, trade unions and The Danish
Working Environment Authority. We thank the reference group for their
support and fruitful discussions. We also wish to thank the SafeChrom
team in Sweden for fruitful discussions and knowledge sharing.
This work was supported by the Danish Working Environment
Research Fund (SAM-Krom, grant numbers 2019 5100 337, 2020 5100
¨
¨
706), Forskningsrådet for halsa, arbeitsliv och v
¨
lf
¨
rd (Forte, grant
a a
¨
number 202000208) and Afa Forsakring (grant number 200279).
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.
org/10.1016/j.ijheh.2024.114444.
References
Abramsson-Zetterberg, L., Zetterberg, G., Bergqvist, M., Grawe, J., 2000. Human
cytogenetic biomonitoring using flow-cytometric analysis of micronuclei in
transferrin-positive immature peripheral blood reticulocytes. Environ. Mol.
Mutagen. 36, 22–31.
Albertini, R.J., Kaden, D.A., 2020. Mutagenicity monitoring in humans: global versus
specific origin of mutations. Mutat. Res. Rev. Mutat. Res. 786, 108341.
Alur, A., Phillips, J., Xu, D., 2024. Effects of hexavalent chromium on mitochondria and
their implications in carcinogenesis. J Environ Sci Health C Toxicol Carcinog 42,
109–125.
Andersen, M.H.G., Saber, A.T., Frederiksen, M., Clausen, P.A., Sejbaek, C.S.,
Hemmingsen, C.H., Ebbehoj, N.E., Catalan, J., Aimonen, K., Koivisto, J., Loft, S.,
Moller, P., Vogel, U., 2021. Occupational exposure and markers of genetic damage,
systemic inflammation and lung function: a Danish cross-sectional study among air
force personnel. Sci. Rep. 11, 17998.
Beattie, H., Keen, C., Coldwell, M., Tan, E., Morton, J., McAlinden, J., Smith, P., 2017.
The use of bio-monitoring to assess exposure in the electroplating industry. J. Expo.
Sci. Environ. Epidemiol. 27, 47–55.
Beskæftigelsesministeriet. The limit value for chromium 6 in the working environment is
tightened [Grænseværdi for chrom 6 i arbejdsmiljøet skærpes].
Beskæftigelsesministeriet.
https://bm.dk/nyheder/pressemeddelelser/2020/02/
graensevaerdi-for-chrom-6-i-arbejdsmiljoeet-skaerpes/.
Bolognesi, C., Bruzzone, M., Ceppi, M., Marcon, F., 2021. Micronuclei and upper body
cancers (head, neck, breast cancers) a systematic review and meta-analysis. Mutat.
Res. Rev. Mutat. Res. 787, 108358.
Bonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W.P., Holland, N., Kirsch-Volders, M.,
Zeiger, E., Ban, S., Barale, R., Bigatti, M.P., Bolognesi, C., Cebulska-Wasilewska, A.,
Fabianova, E., Fucic, A., Hagmar, L., Joksic, G., Martelli, A., Migliore, L.,
Mirkova, E., Scarfi, M.R., Zijno, A., Norppa, H., Fenech, M., 2007. An increased
micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer
in humans. Carcinogenesis 28, 625–631.
Bonde, J.P., Christensen, J.M., 1991. Chromium in biological samples from low-level
exposed stainless steel and mild steel welders. Arch. Environ. Health 46, 225–229.
CEN, 2005. SIST-TP CEN/TR 15230:2005. Workplace Atmospheres - Guidance for
Sampling of Inhalable, Thoracic and Respirable Aerosol Fractions. European
Committee for Standardization.
Costa, C., Silva, S., Neves, J., Coelho, P., Costa, S., Laffon, B., Snawder, J., Teixeira, J.P.,
2011. Micronucleus frequencies in lymphocytes and reticulocytes in a pesticide-
exposed population in Portugal. J. Toxicol. Environ. Health 74, 960–970.
Devoy, J., Gehin, A., Muller, S., Melczer, M., Remy, A., Antoine, G., Sponne, I., 2016.
Evaluation of chromium in red blood cells as an indicator of exposure to hexavalent
chromium: an in vitro study. Toxicol. Lett. 255, 63–70.
Dhillon, V.S., Deo, P., Bonassi, S., Fenech, M., 2021. Lymphocyte micronuclei frequencies
in skin, haematological, prostate, colorectal and esophageal cancer cases: a
systematic review and meta-analysis. Mutat. Res. Rev. Mutat. Res. 787, 108372.
Font-Ribera, L., Marco, E., Grimalt, J.O., Pastor, S., Marcos, R., Abramsson-Zetterberg, L.,
Pedersen, M., Grummt, T., Junek, R., Barreiro, E., Heederik, D., Spithoven, J.,
Critelli, R., Naccarati, A., Schmalz, C., Zwiener, C., Liu, J., Zhang, X., Mitch, W.,
BEU, Alm.del - 2023-24 - Bilag 272: Orientering om nyt studie vedr. udsættelse for krom-6 på danske virksomheder, fra beskæftigelsesministeren
2908998_0015.png
A.T. Saber et al.
Gracia-Lavedan, E., Arjona, L., de Bont, J., Tares, L., Vineis, P., Kogevinas, M.,
Villanueva, C.M., 2019. Exposure to disinfection by-products in swimming pools and
biomarkers of genotoxicity and respiratory damage - the PISCINA2 Study. Environ.
Int. 131, 104988.
Fuglsang, K., Gram, L.K., Markussen, J.B., Kristensen, J.K., 2011. Measurement of
ultrafine particles in emissions from welding processes. In: 16th International
Conference on Joining of Materials, Elsinore, Denmark.
Galea, K.S., Porras, S.P., Viegas, S., Bocca, B., Bousoumah, R., Duca, R.C., Godderis, L.,
Iavicoli, I., Janasik, B., Jones, K., Knudsen, L.E., Leese, E., Leso, V., Louro, H.,
Ndaw, S., Ruggieri, F., Sepai, O., Scheepers, P.T.J., Silva, M.J., Wasowicz, W.,
Santonen, T., 2021. HBM4EU Chromates study - reflection and lessons learnt from
designing and undertaking a collaborative European biomonitoring study on
occupational exposure to hexavalent chromium. Int. J. Hyg Environ. Health 234,
113725.
Hansen, A.M., Mathiesen, L., Pedersen, M., Knudsen, L.E., 2008. Urinary 1-hydroxy-
pyrene (1-HP) in environmental and occupational studies–a review. Int. J. Hyg
Environ. Health 211, 471–503.
HSE. Guidance on respiratory protective equipment (RPE) fit testing. Health and Safety
Executive.
https://www.hse.gov.uk/pubns/indg479.htm.
Højriis, S., Lassen, C., Christensen, F., 2020. Mapping of existing knowledge on exposure
to chromium 6 in Denmark Kortlægning af eksisterende viden om udsættelse for
krom 6 i Danmark. In: Sikkert Arbejde Med Krom, vol. 6. COWI, Lyngby.
IARC, 2012. Arsenic, Metals, Fibres and Dusts. Lyon (FR): International Agency for
Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to
Humans. International Agency for Research on Cancer, Lyon.
IFA, 2024. Gestis - international limit values for chemical agents (Occupational exposure
limits, OELs). Institut für Arbeitsschutz der Deutschen Gesetzlichen
Unfallversicherung.
https://www.dguv.de/ifa/gestis/gestis-internationale-gren
zwerte-fuer-chemische-substanzen-limit-values-for-chemical-agents/index-2.jsp/
(accessed 10 July 2024).
ISO, 2004. ISO 15202-3:2004. Workplace Air
Determination of Metals and Metalloids
in Airborne Particulate Matter by Inductively Coupled Plasma Atomic Emission
Spectrometry. International Organization for Standardization.
Jiang, Z., Schenk, L., Assarsson, E., Albin, M., Bertilsson, H., Dock, E., Hagberg, J.,
Karlsson, L.E., Kines, P., Krais, A.M., Ljunggren, S., Lundh, T., Modig, L., Moller, R.,
Pineda, D., Ricklund, N., Saber, A.T., Storsjo, T., Amir, E.T., Tinnerberg, H.,
Tondel, M., Vogel, U., Wiebert, P., Broberg, K., Engfeldt, M., 2024. Hexavalent
chromium still a concern in Sweden - evidence from a cross-sectional study within
the SafeChrom project. Int. J. Hyg Environ. Health 256, 114298.
Kines, P., Andersen, D., Andersen, L.P., Nielsen, K., Pedersen, L., 2013. Improving safety
in small enterprises through an integrated safety management intervention. J. Saf.
Res. 44, 87–95.
Kines, P., Andersen, L.P.S., Spangenberg, S., Mikkelsen, K.L., Dyreborg, J., Zohar, D.,
2010. Improving construction site safety through leader-based verbal safety
communication. J. Saf. Res. 41, 399–406.
Kirkegaard, M.L., Kines, P., Nielsen, H.B., Garde, A.H., 2018. Occupational safety across
jobs and shifts in emergency departments in Denmark. Saf. Sci. 103, 70–75.
Knudsen, L.E., Boisen, T., Christensen, J.M., Jelnes, J.E., Jensen, G.E., Jensen, J.C.,
Lundgren, K., Lundsteen, C., Pedersen, B., Wassermann, K., et al., 1992.
Biomonitoring of genotoxic exposure among stainless steel welders. Mutat. Res. 279,
129–143.
Koponen, I., Fuglsang, K., Christensen, F., 2021. Measurements of Total Chromiun and
Chromium and 6 in the Working Environment at Selected Companies [Målinger Af
Total-Krom Og Krom 6 I Arbejdsmiljøet På Udvalgte Virksomheder. Lyngby.
Krawic, C., Zhitkovich, A., 2023. Chemical mechanisms of DNA damage by carcinogenic
chromium(VI). Adv. Pharmacol. 96, 25–46.
International Journal of Hygiene and Environmental Health xxx
(xxxx)
xxx
Kristiansen, J., Christensen, J.M., Iversen, B.S., Sabbioni, E., 1997. Toxic trace element
reference levels in blood and urine: influence of gender and lifestyle factors. Sci.
Total Environ. 204, 147–160.
Montero-Montoya, R.D., Lopez-Vargas, R., Mendez-Serrano, A., Galicia-Alonso, I.,
Garcia-Vargas, G., Serrano-Garcia, L., Beltran-Portugal, R., Rosado-Zaidi, S., Albores-
Medina, A., Oropeza-Hernandez, L., Hernandez-Cadena, L., Mercado-Calderon, F.,
Alvarado-Toledo, E., Herrera-Morales, S., Arellano-Aguilar, O., 2020. Increased
micronucleus frequencies in reticulocytes of children exposed to industrial pollution:
oxidative stress and the OGG1 S326C polymorphism. Mutat. Res. Genet. Toxicol.
Environ. Mutagen 853, 503170.
Ndaw, S., Leso, V., Bousoumah, R., R
´
my, A., Bocca, B., Duca, R.C., Godderis, L.,
e
Hardy, E., Janasik, B., van Nieuwenhuyse, A., Pinhal, H., Poels, K., Porras, S.P.,
Ruggieri, F., Santonen, T., Santos, S.R., Scheepers, P.T.J., Silva, M.J., Verdonck, J.,
Viegas, S., Wasowicz, W., Iavicoli, I., 2022. HBM4EU Chromates study - usefulness of
measurement of blood chromium levels in the assessment of occupational Cr(VI)
exposure. Environ. Res. 214, 113758.
Nielsen, K., Kines, P., Pedersen, L.M., Andersen, L.P., Andersen, D.R., 2015. A multi-case
study of the implementation of an integrated approach to safety in small enterprises.
Saf. Sci. 71, 142–150.
Nübler, S., Sch
¨
fer, M., Haji-Abbas-Zarrabi, K., Markovi
´
, S., Markovi
´
, K., Esteban
a
c
c
´
˜
Lopez, M., Castano, A., Mol, H., Koch, H.M., Antignac, J.P., Hajslova, J.,
¨
Thomsen, C., Vorkamp, K., Goen, T., 2022. Interlaboratory Comparison
Investigations (ICIs) for human biomonitoring of chromium as part of the quality
assurance programme under HBM4EU. J. Trace Elem. Med. Biol. : organ of the
Society for Minerals and Trace Elements (GMS) 70, 126912.
Offer, T., Ho, E., Traber, M.G., Bruno, R.S., Kuypers, F.A., Ames, B.N., 2005. A simple
assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry
of human reticulocytes. Faseb. J. 19, 485–487.
Santonen, T., Porras, S.P., Bocca, B., Bousoumah, R., Duca, R.C., Galea, K.S., Godderis, L.,
¨
Goen, T., Hardy, E., Iavicoli, I., Janasik, B., Jones, K., Leese, E., Leso, V., Louro, H.,
Majery, N., Ndaw, S., Pinhal, H., Ruggieri, F., Silva, M.J., van Nieuwenhuyse, A.,
Verdonck, J., Viegas, S., Wasowicz, W., Sepai, O., Scheepers, P.T.J., 2022. HBM4EU
Chromates study - overall results and recommendations for the biomonitoring of
occupational exposure to hexavalent chromium. Environ. Res. 204, 111984.
Serageldin, M., Reeves, D.W., 2009. Development of welding emission factors for Cr and
Cr(VI) with a confidence level. J. Air Waste Manag. Assoc. 59, 619–626.
Statistics Denmark, 2010. Statistics Denmark’s Classification of Occupations (DISCO-08),
V1:2010. Statistics Denmark.
Statistics Denmark, 2014. Dansk Branchekode DB07, V3:2014-. Statistics Denmark.
´
Tavares, A., Aimonen, K., Ndaw, S., Fu
ˇ
i
´
, A., Catalan, J., Duca, R.C., Godderis, L.,
cc
Gomes, B.C., Janasik, B., Ladeira, C., Louro, H., Namorado, S., Nieuwenhuyse, A.V.,
Norppa, H., Scheepers, P.T.J., Ventura, C., Verdonck, J., Viegas, S., Wasowicz, W.,
Santonen, T., Silva, M.J., On Behalf Of The Hbm Eu Chromates Study, T., 2022.
HBM4EU chromates study-genotoxicity and oxidative stress biomarkers in workers
exposed to hexavalent chromium. Toxics 10.
U.S, E.P.A., 2007. USEPA SW-846 METHOD 6800. Elemental and Molecular Speciated
Isotope Dilution Mass Spectrometry. U.S. Environmental Protection Agency.
Verdonck, J., Duca, R.C., Galea, K.S., Iavicoli, I., Poels, K., Toreyin, Z.N., Vanoirbeek, J.,
Godderis, L., 2021. Systematic review of biomonitoring data on occupational
exposure to hexavalent chromium. Int. J. Hyg Environ. Health 236, 113799.
Viegas, S., Martins, C., Bocca, B., Bousoumah, R., Duca, R.C., Galea, K.S., Godderis, L.,
Iavicoli, I., Janasik, B., Jones, K., Leese, E., Leso, V., Ndaw, S., van
Nieuwenhuyse, A., Poels, K., Porras, S.P., Ruggieri, F., Silva, M.J., Verdonck, J.,
Wasowicz, W., Scheepers, P.T.J., Santonen, T., Hbm Eu Chromates Study, T., 2022.
HBM4EU chromates study: determinants of exposure to hexavalent chromium in
plating, welding and other occupational settings. Int. J. Environ. Res. Publ. Health
19.
15